Mumbai, India , is rapidly emerging as a vital hub for the manufacture of Lenacapavir Sodium API (CAS 2189684-53-3). Several firms have established robust manufacturing facilities focusing on this critical antiviral drug . Identifying the absolute top manufacturers can be challenging due to fluct